https://www.selleckchem.com/products/amg-232.html
01, false discovery rate less then 0.25) in the high-SLC2A1 expression group. SLC2A1 is a promising biomarker that can be used to predict the prognosis of LUAD.OBJECTIVES To evaluate the benefits of a primary progressive aphasia (PPA) education and support session for people with PPA (pwPPA) and their caregivers. METHOD Thirty-eight individuals (20 pwPPA, 18 caregivers) were invited to participate in the study. Twenty-five individuals (12 pwPPA, 13 caregivers) completed questionnaires before and after an education and support group sess
Like
Comment
Share
